We investigated the association of serum FGF21, FGF19 and liver Klotho coreceptor with non-alcoholic steatohepatitis (NASH) and fibrosis in children with NAFLD. This evidence concerns the gene FGF19 and metabolic dysfunction-associated steatohepatitis.